[Development of new specific inhibitors for cathepsins and its application for medical field].
Katunuma
N
N
Institute for Health Sciences, Tokushima Bunri University, Japan.
Tsuge
H
H
Asao
T
T
D000818:Animals; D002403:Cathepsins / Q000037:antagonists & inhibitors* / Q000502:physiology; D018360:Crystallography, X-Ray; D004151:Dipeptides / Q000494:pharmacology; D015195:Drug Design; D008968:Molecular Conformation; D011422:Propionates / Q000494:pharmacology; D011736:Pyridoxine / Q000031:analogs & derivatives / Q000494:pharmacology
C406022:CLIK 164; D004151:Dipeptides; D011422:Propionates; C068249:N-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline; C068250:N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline; D002403:Cathepsins; D011736:Pyridoxine